# Quantum X Labs Inc.: overview QXL · Nasdaq · CIK 797542 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/qxl.md) · [Financials](/companies/qxl/financials.md) · [Filings](/companies/qxl/filings.md) · [Insiders](/companies/qxl/insiders.md) Latest reported revenue: [$293.0k](/filings/0001493152-26-037811.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001493152-26-037811). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [6,281](/filings/0001493152-25-023501.md) | [3,325 d](/filings/0001493152-25-011100.md) | [2,733](/filings/0001641172-25-010059.md) | [2,281](/filings/0001641172-25-024831.md) | [2,717](/filings/0001493152-25-023501.md) | not reported | not reported | [293](/filings/0001493152-26-037811.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(14.4%)](/filings/0001493152-25-023501.md) | [197.3% d](/filings/0001493152-26-013205.md) | [(2.0%)](/filings/0001493152-26-023169.md) | [(44.8%)](/filings/0001493152-26-037811.md) | [(133.7%)](/filings/0001493152-25-023501.md) | not reported | not reported | [(476.1%)](/filings/0001493152-26-037811.md) | | Net margin | % | [(9.4%)](/filings/0001493152-25-023501.md) | [(98.9%) d](/filings/0001493152-26-013205.md) | [(134.2%)](/filings/0001493152-26-023169.md) | [(511.1%)](/filings/0001493152-26-037811.md) | [(124.9%)](/filings/0001493152-25-023501.md) | not reported | not reported | [848.1%](/filings/0001493152-26-037811.md) | | Diluted EPS | $ per share | [0.12](/filings/0001493152-25-023501.md) | not reported | [0.68](/filings/0001493152-26-023169.md) | [(1.61)](/filings/0001493152-26-037811.md) | [0.32](/filings/0001493152-25-023501.md) | not reported | [0.05](/filings/0001493152-26-023169.md) | [0.12](/filings/0001493152-26-037811.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(1,248)](/filings/0001493152-26-037811.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [45.2](/filings/0001493152-23-008765.md) | [96.6](/filings/0001493152-24-011132.md) | [79.6](/filings/0001493152-25-011100.md) | [26.9](/filings/0001493152-25-011100.md) | not reported | | Gross margin | % | [0.1%](/filings/0001493152-22-007150.md) | not reported | not reported | not reported | not reported | | Operating margin | % | [1.2%](/filings/0001493152-23-008765.md) | [2.8%](/filings/0001493152-24-011132.md) | [(9.4%)](/filings/0001493152-25-011100.md) | [(3.1%)](/filings/0001493152-26-013205.md) | not reported | | Net margin | % | [0.7%](/filings/0001493152-23-008765.md) | [0.0%](/filings/0001493152-24-011132.md) | [(9.2%)](/filings/0001493152-25-011100.md) | [(44.7%)](/filings/0001493152-26-013205.md) | not reported | | Diluted EPS | $ per share | [0.01](/filings/0001493152-22-007150.md) | [0.00](/filings/0001493152-24-011132.md) | [1.97](/filings/0001493152-25-011100.md) | [2.69](/filings/0001493152-26-013205.md) | [2.28](/filings/0001493152-26-013205.md) | | Free cash flow | $m | [4.1](/filings/0001493152-23-008765.md) | [3.2](/filings/0001493152-24-011132.md) | [0.9](/filings/0001493152-25-011100.md) | [1.5](/filings/0001493152-25-011100.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/qxl/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [MMCAP International Inc. SPC](/funds/1304857.md) | 2026-06-30 | $2.1m | 361,573 | | Added +245,578 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $75.6k | 13,266 | | Added +12,002 | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $65.5k | 11,498 | | New +11,498 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $570 | 100 | | New +100 | | [HRT FINANCIAL LP](/funds/1475597.md) | 2026-06-30 | $249 | 43,819 | | New +43,819 | | [BANK HAPOALIM BM](/funds/902528.md) | 2026-06-30 | $114 | 20,000 | | New +20,000 | | [Caitong International Asset Management Co., Ltd](/funds/1963355.md) | 2026-06-30 | $57 | 10 | | New +10 | ## Recent filings [All 349 filings](/companies/qxl/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-22 | 16:30 ET | [8-K](/filings/0001493152-26-043718.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-043718 | | 2026-09-15 | 07:52 ET | [8-K](/filings/0001493152-26-042665.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042665 | | 2026-08-13 | 16:31 ET | [10-Q](/filings/0001493152-26-037811.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037811 | | 2026-05-29 | 08:30 ET | [8-K](/filings/0001493152-26-025728.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-025728 | | 2026-05-15 | 16:30 ET | [8-K](/filings/0001493152-26-023849.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-023849 | | 2026-05-14 | 17:03 ET | [10-Q](/filings/0001493152-26-023169.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023169 | | 2026-05-14 | 16:15 ET | [8-K](/filings/0001493152-26-023096.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-023096 | | 2026-04-30 | 09:20 ET | [8-K](/filings/0001493152-26-019787.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-019787 | | 2026-04-21 | 09:00 ET | [8-K](/filings/0001493152-26-018217.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018217 | | 2026-03-27 | 16:15 ET | [10-K](/filings/0001493152-26-013205.md) | Annual report, period 2025-12-31 | 0001493152-26-013205 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-013205.md), filed Mar 27, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/3ddc3051-713f-42b9-a7e6-6f171b8c0162) ## About the filer - CIK: 797542 - Tickers: QXL - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.